Skip to content

Clinical trials

Phase 3 Leukemia, Myelomonocytic, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Phase 3 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20131
20172
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Astex Pharmaceuticals, Inc.2
Traws Pharma, Inc.2
European Working Group of MDS in Childhood1
Novartis Pharmaceuticals1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic10
Myelodysplastic Syndromes8
Anemia, Refractory, with Excess of Blasts4
Leukemia3
Leukemia, Myeloid, Acute3
Anemia, Refractory2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative2
Myelodysplastic-Myeloproliferative Diseases2
Myeloproliferative Disorders2
Blast Crisis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.